The AHA today participated in a White House forum on ways to improve responsible antibiotic use, where more than 150 stakeholders committed to help thwart the public health and national security threat posed by antibiotic-resistant bacteria. The AHA and six national partners last year released a toolkit to help hospitals and health systems develop and enhance their antimicrobial stewardship programs. Representing AHA at the White House event was Roberta DeBiasi, M.D., chief of the Division of Pediatric Infectious Diseases at Children's National Medical Center in Washington, DC, and professor of pediatrics and microbiology, immunology and tropical medicine at The George Washington University School of Medicine. Hospital and health system representatives at the event included Jonathan Perlin, M.D., president of clinical services and chief medical officer for Hospital Corporation of America and AHA chairman. In related news, the Department of Health and Human Services announced a $20 million competition to develop rapid point-of-care diagnostics to combat antibiotic-resistant bacteria.

Related News Articles

Headline
In clinical trials involving 220,000 patients at 59 HCA Healthcare hospitals, algorithm-driven computerized alerts helped clinicians better identify the…
Headline
After declining in recent years, antimicrobial-resistant infections starting during hospitalization grew 15% from 2019 to 2020, the Centers for Disease Control…
Headline
The Centers for Disease Control and Prevention today updated its Core Elements for Hospital Antibiotic Stewardship Programs to reflect experience and evidence…
Headline
Antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths in the United States each year, according to a report released…
Headline
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA,…
Headline
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia. The antibiotic, Xenleta…